Literature DB >> 1409563

A structural model for human dihydrolipoamide dehydrogenase.

J E Jentoft1, M Shoham, D Hurst, M S Patel.   

Abstract

The hypothesis that dihydrolipoamide dehydrogenases (E3s) have tertiary structures very similar to that of human glutathione reductase (GR) was tested in detail by three separate criteria: (1) by analyzing each putative secondary structural element for conservation of appropriate polar/nonpolar regions, (2) by detailed comparison of putative active site residues in E3s with their authentic counterparts in human GR, and (3) by comparison of residues at the putative dimeric interface of the E3s with the authentic residues in GR. All three criteria are satisfied in a convincing way for the 7 E3s that were considered, supporting the conclusion that the structural scaffolding and the overall tertiary structure (which determines the location of functional sites and residues) are remarkably similar for the E3s and for GR. These analyses together with the crystal structures of human erythrocyte GR formed the basis for construction of a molecular model for human E3. The cofactor FAD and the substrates NAD and lipoic acid were also included in the model. Unexpectedly, the surface residues in the cleft that holds the lipoamide were found to be highly charged and predominantly acidic, allowing us to predict that the region around the lipoamide in the subunit should be basic in nature. The molecular model can be tested by site-directed mutagenesis of residues predicted to be in the dihydrolipoamide acetyltransferase subunit binding cleft.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409563     DOI: 10.1002/prot.340140110

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  6 in total

1.  Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient.

Authors:  T C Liu; H Kim; C Arizmendi; A Kitano; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

2.  Yeast intragenic transcriptional control: activation and repression sites within the coding region of the Saccharomyces cerevisiae LPD1 gene.

Authors:  D A Sinclair; G D Kornfeld; I W Dawes
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

3.  Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation.

Authors:  Olga Grafakou; Konrad Oexle; Lambert van den Heuvel; Roel Smeets; Frans Trijbels; Hans H Goebel; Nils Bosshard; Andrea Superti-Furga; Beat Steinmann; Jan Smeitink
Journal:  Eur J Pediatr       Date:  2003-08-19       Impact factor: 3.183

4.  Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain.

Authors:  Liang-Jun Yan; Nopporn Thangthaeng; Michael J Forster
Journal:  Mech Ageing Dev       Date:  2008-02-06       Impact factor: 5.432

5.  Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress.

Authors:  Xiaojuan Yang; Jing Song; Liang-Jun Yan
Journal:  Antioxidants (Basel)       Date:  2019-02-02

6.  SiteMotif: A graph-based algorithm for deriving structural motifs in Protein Ligand binding sites.

Authors:  Santhosh Sankar; Nagasuma Chandra
Journal:  PLoS Comput Biol       Date:  2022-02-24       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.